机译:肾母细胞瘤的KIT,PDGFRα和EGFR分析
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Institute for Pathology University Hospital Schleswig-Holstein Campus Kiel Michaelisstrasse 11 24105 Kiel Germany;
Institute for Pathology University Hospital Schleswig-Holstein Campus Kiel Michaelisstrasse 11 24105 Kiel Germany;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Department of Paediatric Oncology University Children’s Hospital Building 9 66421 Homburg Germany;
Department of Paediatric Oncology University Children’s Hospital Building 9 66421 Homburg Germany;
Department of Paediatric Oncology/Haematology University Children’s Hospital Römergasse 8 CH-4005 Basel Switzerland;
Institute for Histologic and Cytologic Diagnostics Dammweg 1 CH-5001 Aarau Switzerland;
Institute for Clinical Chemistry and Laboratory Medicine University of Regensburg Franz-Josef Strauß Allee 11 93053 Regensburg Germany;
Institute for Clinical Chemistry and Laboratory Medicine University of Regensburg Franz-Josef Strauß Allee 11 93053 Regensburg Germany;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Institute for Pathology Basel University Hospital Schoenbeinstrasse 40 CH-4031 Basel Switzerland;
Nephroblastoma; KIT-PDGFRα-EGFR mutation analysis; Tyrosine kinase inhibition; KIT-EGFR immunohistochemistry;
机译:肾母细胞瘤的KIT,PDGFRalpha和EGFR分析。
机译:显示胸腺样成分的癌症中的KRAS,EGFR,PDGFR-α,KIT和COX-2状态(CASTLE)
机译:胸膜肺孤立性纤维性肿瘤:88例临床病理,免疫组织化学和分子研究,证实了de Perrot分期系统和p53表达的预后价值,并评估了c-kit,BRAF,PDGFRs(alpha / beta),c -met和EGFR。
机译:肾母细胞瘤中基于miRNA的途径分析工具作为其他癌症领域原理的证明
机译:EGFR-TKIs在非小细胞肺癌治疗中的有效性:一项荟萃分析。
机译:显示胸腺样成分的癌症中的KRASEGFRPDGFR-αKIT和COX-2状态(CASTLE)
机译:显示胸腺样成分的癌症中的KRAS,EGFR,PDGFR-α,KIT和COX-2状态(CASTLE)